IN VITRO DEMONSTRATION OF HUMORAL AND CELL-BOUND IMMUNITY AGAINST COMMON SPECIFIC TRANSPLANTATION ANTIGEN(S) OF ADENOVIRUS 12-INDUCED MOUSE AND HAMSTER TUMORS

por Hellström, Ingegerd, Sjögren, Hans O.
Publicado 1967

Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy

por Wei, Huafeng, Zhao, Likun, Hellstrom, Ingegerd, Hellstrom, Karl Erik, Guo, Yajun
Publicado 2014

Tumor Regression and Cure Depends on Sustained Th1 Responses

por Dai, Min, Hellstrom, Ingegerd, Yip, Yuen Y., Sjögren, Hans Olov, Hellstrom, Karl Erik
Publicado 2018

Human and Mouse CD137 Have Predominantly Different Binding CRDs to Their Respective Ligands

por Yi, Ling, Zhao, Yanlin, Wang, Xiaojue, Dai, Min, Hellström, Karl Erik, Hellström, Ingegerd, Zhang, Hongtao
Publicado 2014

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors

por Yu, Yi, Edassery, Seby L, Barua, Animesh, Abramowicz, Jacques S, Bahr, Janice M, Hellstrom, Ingegerd, Luborsky, Judith L
Publicado 2011

WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

por Bingle, Lynne, Cross, Simon S, High, Alec S, Wallace, William A, Rassl, Doris, Yuan, Guanglu, Hellstrom, Ingegerd, Campos, Michael A, Bingle, Colin D
Publicado 2006

Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin

por Wei, Huafeng, Zhao, Likun, Li, Wei, Fan, Kexing, Qian, Weizhu, Hou, Sheng, Wang, Hao, Dai, Min, Hellstrom, Ingegerd, Hellstrom, Karl Erik, Guo, Yajun
Publicado 2013